Amino Acids, Peptides, and Proteins: News and Research on Blood Coagulation Factors

MeSH tree: D12.776.124.125

FDA approves Hympavzi for hemophilia

The U.S. Food and Drug Administration (FDA) approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with ...

page 6 from 13